SplitApr 14, 2026, 04:07 PM
Immunic Board Approves Reverse Stock Split
AI Summary
Immunic, Inc. held a Special Meeting of Stockholders where a proposal to authorize the Board of Directors to effect a reverse stock split was approved. The approved ratio range for the split is 1-for-10 to 1-for-30, with the exact ratio to be determined by the Board within one year. Following the stockholder approval, the Board officially approved the reverse stock split of the company's common stock.
Key Highlights
- Stockholders approved authorization for a reverse stock split.
- The approved ratio range for the split is 1-for-10 to 1-for-30.
- 57,404,749 votes were cast in favor of the proposal.
- The Board of Directors subsequently approved the reverse stock split.